GlassScriptPhysician profile
Leslie Bolander
NPI 1396154977
$1,007.81
in general payments reported to CMS, 2019-2025
19 companies · $32.25 in 2025
The $32.25 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $272 · 2023: $431 · 2024: $273 · 2025: $32.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $735.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $193.37 | 2022-2023 | |
| Abbvie INC. | $156.82 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $132.49 | 2022-2024 | |
| Organon LLC | $102.21 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $81.95 | 2023 | Myfembree |
| Hologic Sales and Service, LLC | $65.28 | 2022-2024 | Aptima |
| Coopersurgical, INC. | $55.66 | 2024 | Paragard T 380a |
| Astellas Pharma US INC | $40.54 | 2024 | Veozah |
| Shield Therapeutics INC | $26.63 | 2024 | |
| Myovant Sciences INC. | $20.20 | 2022 | |
| Boston Scientific Corporation | $18.57 | 2025 | General - Pain Management |
| Smith+Nephew, INC. | $16.56 | 2024 | Pico 14, Pico 7, Renasys Touch |
| Evofem Biosciences, INC. | $15.91 | 2022 | |
| Myriad Women'S Health, INC. | $14.47 | 2023 | Myrisk |
| Gynesonics, INC. | $14.32 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $13.69 | 2023 | Balcoltra |
| Optumhealth Care Solutions, LLC | $13.68 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Pfizer INC. | $13.46 | 2024 | |
| Ethicon US, LLC | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Bolander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.